Did CEO Jeff Kindler get pushed out because he was shaking up the dysfunctional pharmaceutical giant -- or because he's an ineffective leader?
China will spend billions on biotech, even as the industry struggles in the U.S. to turn research into gold. Will U.S. biotech become the next Detroit?
A huge part of Allergan's patent-cliff immunity against other big pharmaceuticals is its blockbuster Botox, which has helped the company evade the patent problems facing others in the industry.
India's Ranbaxy won the right to make a generic version of the $11 billion drug -- only to be accused of seri ous fraud and shoddy practices in another case. Now a fight is erupting over the mega-popular cholesterol medication.
When it comes to in-flight pampering, the amenity kits offered by these 10 airlines are the ultimate in luxury
From a text therapy platform to apps that push you reminders to breathe, these self-care startups offer help on a daily basis or in times of need.
From Uber's flying cars to the Hyperloop, these are some of the neatest transportation concepts in the works today.
Meghan Markle's wedding to Prince Harry could cost millions once security is included in the bill. See how the costs break down.
Experts believe humans and machines will work much more closely together.
Smart telescopes, surveillance for dogs, an electric roadster and more from CES 2018.
For the price of a premium class ticket, you may just get a space that's comfortable, private, and quiet enough to ensure a good rest.
The biggest tech show of the year opened with a collection of quirky gadgets.
From smart mirrors to virtual reality, these store concepts tease the future of shopping.
